Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?

Journal of Women's Health

Volumn 17, Issue 5, 2008, Pages 841-847

  Brown, Todd M ^a,b   Vaidya, Dhananjay ^c   Rogers, William J ^b   Waters, David D ^d   Howard, Barbara V ^e   Tardif, Jean Claude ^f   Bittner, Vera ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MEDSTAR RESEARCH INSTITUTE   (United States)

^f MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ADULT TREATMENT PANEL III CRITERION; AGED; ANGIOGRAPHY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; EUROPEAN AMERICAN; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INTERMETHOD COMPARISON; INTERNATIONAL DIABETES FEDERATION CRITERION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; ORGANIZATION; PATIENT CODING; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERGLYCEMIA; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREVALENCE; RISK ASSESSMENT; UNITED STATES; WOMEN'S HEALTH;

EID: 45149094319     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0536     Document Type: Article

References (24)

1. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143.
2. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, for the Conference Participants. Definition of the metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004;109:433.
3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among U.S. adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356.
4. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Stroke 2006;37:1583.
5. The IDF consensus worldwide definition of the metabolic syndrome. Available at www.idf.org/webdata/docs/MetS_def_update2006.pdf Accessed June 14, 2007.
6. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745.
7. Rathmann W, Haastert B, Icks A, et al. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: The KORA Survey 2000. Diabetes Care 2006;29:461.
8. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 2006;29:685.
9. Adams RJ, Appleton S, Wilson DH, et al. Population comparison of two clinical approaches to the metabolic syndrome: Implications of the new International Diabetes Federation consensus definition. Diabetes Care 2005;28:2777.
10. Guerrero-Romero F, Rodriguez-Moran M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care 2005;28:2588.
11. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN. The importance of waist circumference in the definition of metabolic syndrome. Diabetes Care 2006;29:404.
12. Boulon C, Lafitte M, Richeboeuf V, et al. Prevalence of metabolic syndrome after acute coronary syndrome and its prognostic significance. Am J Cardiol 2006;98:1429.
13. Bo S, Ciccone G, Pearce N, et al. Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects. Diabetes Res Clin Pract 2007;75:362.
14. Gonzalez-Ortiz M, Martinez-Abundis E, Jacques-Camarena O, Hernandez-Gonzalez SO, Valera-Gonzalez IG, Ramos-Zavala MG. Prevalence of metabolic syndrome in adults with excess of adiposity: Comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition. Acta Diabetol 2006;43:84.
15. Echahidi N, Pibarot P, Despres J-P, et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol 2007;50:843.
16. Kragelund C, Kober L, Faber J, Steffensen R, Hildebrandt P. Metabolic syndrome and mortality in stable coronary heart disease: Relation to gender. Int J Cardiol 2007;121:62.
17. Waters DD, Alderman EL, Hsia J, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial. JAMA 2002;288:2432.
18. Hsia J, Bittner V, Tripputi M, Howard BV. Metabolic syndrome and coronary angiographic disease progression: The Women's Angiographic Vitamin and Estrogen trial. Am Heart J 2003;146:439.
19. Hsia J, Alderman EL, Verter JL, et al. Women's Angiographic Vitamin & Estrogen trial: Design and methods. Control Clin Trial 2002;23:708.
20. Skilton MR, Moulin P, Serusclat A, Nony P, Bonnet F. A comparison of the NCEP-ATPIII, IDF, and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: Evidence for sex-specific differences. Atherosclerosis 2007;190:416.
21. Saely CH, Koch L, Schmid F, et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006;29:901.
22. Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol 2007;117:204.
23. Lawlor DA, Smith GD, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 2006;49:41.
24. The DECODE study group, Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837.